Common Contracts
2 similar Seventh Supplemental Indenture contracts by Valeant Pharmaceuticals International, Inc.
SEVENTH SUPPLEMENTAL INDENTURESeventh Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
SEVENTH SUPPLEMENTAL INDENTURE, dated as of August 30, 2013 (the “Seventh Supplemental Indenture”), by and among Bausch & Lomb Holdings Incorporated (“BLH”), Bausch & Lomb Incorporated (“BLI”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
SEVENTH SUPPLEMENTAL INDENTURESeventh Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
SEVENTH SUPPLEMENTAL INDENTURE, dated as of August 30, 2013 (the “Seventh Supplemental Indenture”), by and among Bausch & Lomb Holdings Incorporated (“BLH”), Bausch & Lomb Incorporated (“BLI”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
